MCh Neurosurgery: Admission, Medical School, Fees, Qualification Info

Published Date: 01 Mar 2023

Chirurgiae Master of Neurosurgery, also known as MCh Neurosurgery or MCh of Neurosurgery, is the highest level of training for doctors in India...

Read Full News

Latest News

Adrian Harris: Why Oncology Must Look Beyond Cancer Cells

Many promising therapies fail because of poor patient selection; Harris warns that only about one third of tumors are truly hypoxic, underscoring the need for precise biomarkers in trials.

‘Impossible’ Now Possible: Making Brain Tissue Transparent

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca's Imfinzi With Pre-surgery Drug Boosts Survival in Bladder Cancer Trial

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

STS: Society of Thoracic Surgeons

Jehovah's Witnesses Transfusion Policy Now Allows Storage, Use of One's Own Blood

"I don't think it goes far enough, but it's a significant change," said one former member

Nobel-Winning Doctor Dies; 'Buffy' Star's Heart Defect; Cyberattack Delays Surgeries

Health news and commentary gathered by MedPage Today staff

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Latest News

Many promising therapies fail because of poor patient selection; Harris warns that only about one third of tumors are truly hypoxic, underscoring the need for precise biomarkers in trials.

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

"I don't think it goes far enough, but it's a significant change," said one former member

Health news and commentary gathered by MedPage Today staff

News All Time

Ask the HF Expert: Managing Congestion

Chief fellow Yash Varma asks heart failure expert Ileana Piña for her tips and tricks in managing patients admitted with acute decompensated heart failure.

They Say Compassion Drains You. Science Disagrees

Research suggests it’s not compassion that wears doctors down but a different emotion — a distinction that may help them recharge more effectively.

UK and US Set Path to Shared Medical Device Approvals

The MHRA and FDA have agreed to explore mutual recognition of medical device approvals, in a move that could cut delays for patients in both countries.

You Haven’t Aged a Day: The Prognostic Value of Facial Aging

An AI study suggests that the rate of facial aging could be a biomarker for cancer mortality.

Intraoperative Irradiation Safe for Breast Cancer Relapse

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients with late local recurrence of breast cancer.

Pancreatic Cancer: Should Surgery or Chemo Come First?

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with operable pancreatic cancer. Here’s what we know.

Surgical Robots: NHS Ambition Outpacing Delivery

RCS England finds no national strategy for funding or distributing surgical robots, leaving some hospitals reliant on local fundraising.

NDAs Are Illegal in Healthcare, Says Ethicist

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

BC Rate Low in BRCA Carriers After Risk-Reducing Mastectomy

Researchers conduct a study of more than 1000 women with BRCA1 or BRCA2 mutations to compare breast cancer rates between those who do and do not undergo mastectomy.

Physalis minima (Golden Cherry)

Also known as golden cherry, Physalis minima is used often to treat inflammation, neurodegenerative disorders, and cancer in East Malaysian traditional medicine.